search
Back to results

Obstructive Sleep Apnea - Patient Specific Factors, Success Rate and Compliance

Primary Purpose

Sleep Apnea, Obstructive

Status
Unknown status
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
CPAP
Mandibular Advancing Splint
Sponsored by
University of Tromso
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Sleep Apnea, Obstructive focused on measuring Continuous Positive Airway Pressure, Mandibular Advancing Splint, Efficacy, Compliance, Health related quality of life, Randomized Controlled Trial, Snoring, Mandibular Advancing Appliance, Mandibular Advancing Device, Humans, Quality of Life, Sleep Apnea, Obstructive

Eligibility Criteria

20 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • 10 ≤ Apnea-Hypopnea-Index ≤ 30 at baseline
  • Subjective symptoms of OSA
  • Ability of at least 5mm protrusion of the mandible
  • Accept randomization of treatment modality
  • Accept to fill in the questionnaires
  • Accept to attend at planned consultations

Exclusion Criteria:

  • Primarily central sleep apnea
  • Known temporomandibular dysfunction (TMD)
  • Mental instability
  • Drug abuse
  • Extensive usage of sedative medication which disqualifies for OSA-treatment
  • Extensive gag-reflex or claustrophobia
  • Inadequate dental support (< 10 teeth in lower jaw)
  • Inadequate periodontal support (no tooth mobility > Miller grade I)
  • Anatomical abnormalities in the nasal cavity or oro-pharynx that disqualifies the use of CPAP and/or MAS
  • Anatomical abnormalities which should be surgically corrected before treatment with CPAP and/or MAS
  • Severely compromised general health condition
  • Pregnancy
  • General health issues that disqualifies the use of CPAP and or MAS

Sites / Locations

  • St.Olavs Hospital
  • University Hospital of North Norway

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Continuous Positive Airway Pressure

Mandibular Advancing Splint

Arm Description

Patients treated With an auto-CPAP-machine which is a compressor Connected to a nose- or face mask which provides increased air pressure, opening the upper Airways during an apnea or hypopnea event.

Patients treated With a twin block splint (oral appliance) advancing the mandible and thereby opening the upper Airways for easier passage of air during sleep preventing apnea and hypopnea events.

Outcomes

Primary Outcome Measures

Association between patient characteristics and adherence to treatment With either CPAP or MAS
Combining measurements from questionnaires at baseline and 12 months to map the patient characteristics of those patients treated for mild or moderate OSA who comply, or do not comply to CPAP-intervention or MAS-intervention respectively. Detailed description of measurements collected are listed in secondary outcome measures.

Secondary Outcome Measures

Efficacy of MAS and CPAP measured by Apnea-Hypopnea-Index (AHI). Data collected by respiratory polygraphy.
Objective measurement of the efficacy of MAS or CPAP treatment in patients having mild or moderate OSA. Apnea-events/hypopnea-events and oxygen desaturation-index registered by respiratory polygraphy are combined to give an AHI-score before treatment and after 4 months of intervention.
Efficacy of MAS and CPAP measured by Apnea-Hypopnea-Index (AHI). Data collected by respiratory polygraphy.
Objective measurement of the efficacy of MAS or CPAP treatment in patients having mild or moderate OSA. Apnea-events/hypopnea-events and oxygen desaturation-index registered by respiratory polygraphy are combined to give an AHI-score before treatment and after 12 months of intervention.
Self-reported patient compliance to MAS or CPAP collected by questionnaire
Patient adherence to the use of MAS or CPAP in patients having mild or moderate OSA
Self-reported patient compliance to MAS or CPAP collected by questionnaire
Patient adherence to the use of MAS or CPAP in patients having mild or moderate OSA
Self-reported quality of life collected by the questionnaire Short Form-36 (SF-36)
Health related Quality of life at baseline and after 4 months of treatment with either MAS or CPAP in patients having mild or moderate OSA
Self-reported quality of life collected by the questionnaire Short Form-36 (SF-36)
Health related Quality of life at baseline and after 12 months of treatment with either MAS or CPAP in patients having mild or moderate OSA
Self-reported symptoms of anxiety and/or depression collected by the questionnaire Hospital Anxiety and Depression Scale (HADS)
Self reported signs on depression and anxiety at baseline and after 4 months of treatment with either MAS or CPAP in patients having mild or moderate OSA
Self-reported symptoms of anxiety and/or depression through the questionnaire Hospital Anxiety and Depression Scale (HADS)
Self reported signs on depression and anxiety at baseline and after 12 months of treatment with either MAS or CPAP in patients having mild or moderate OSA
Self-reported experience of sleep-quality through the questionnaire Pittsburgh Sleep Quality Index (PSQI)
Self perceived sleep quality at baseline and after 4 months of treatment with either MAS or CPAP in patients having mild or moderate OSA
Self-reported experience of sleep-quality through the questionnaire Pittsburgh Sleep Quality Index (PSQI)
Self perceived sleep quality at baseline and after 12 months of treatment with either MAS or CPAP in patients having mild or moderate OSA

Full Information

First Posted
February 26, 2016
Last Updated
April 30, 2019
Sponsor
University of Tromso
Collaborators
University Hospital of North Norway, Public Dental Service Competence Centre of Northern Norway, St. Olavs Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT02953028
Brief Title
Obstructive Sleep Apnea - Patient Specific Factors, Success Rate and Compliance
Official Title
Treatment of Mild and Moderate Obstructive Sleep Apnea (OSA) by Continuous Positive Airway Pressure (CPAP) or Mandibular Advancing Splint (MAS) - a Randomized Controlled Trial on Patient Specific Factors, Success Rate and Compliance
Study Type
Interventional

2. Study Status

Record Verification Date
April 2019
Overall Recruitment Status
Unknown status
Study Start Date
October 2014 (Actual)
Primary Completion Date
August 2019 (Anticipated)
Study Completion Date
December 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Tromso
Collaborators
University Hospital of North Norway, Public Dental Service Competence Centre of Northern Norway, St. Olavs Hospital

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Obstructive sleep apnea (OSA) is a condition where the patient's breathing cease during sleep due to collapse of the oro-pharynx. The consequences are reduced quality of sleep, increased risk for developing cardiovascular disease and increased risk of accidents caused by daytime sleepiness. Among Norwegians 30-65 yrs, the prevalence of OSA are estimated to 16%. The golden standard in OSA-treatment is Continuous Positive Airway Pressure (CPAP). This is effective and must be used for life. However, CPAP-treatment might be uncomfortable for the patient, with poor compliance as a result. An alternative is Mandibular Advancing Splints (MAS), which is perceived as less troublesome and may initiate higher compliance. Through mapping of patient characteristics, the researchers investigate which patient-type benefits most from two different treatment-devices. The aim of the study is to assess how the MAS treatment differ from the CPAP treatment in respect to efficacy, compliance and impact on health related quality of life among patient diagnosed with mild/moderate OSA. All OSA patients referred to the Ear- Nose- Throat-department (ENT) at University Hospital, Northern-Norway (UNN) and St.Olavs Hospital were invited to participate in the study. The sample size at completion of the study should be 140 patients. Participants in the trial were randomly allocated to the two treatment groups, and assessed after 4 and 12 months of treatment. Data were collected through anamnesis, clinical examination, clinical photos, radiographs and questionnaires concerning general health related quality of life (SF36), oral health, cognitive aspects (HADS), sleep quality (PSQI), daytime sleepiness (Epworth's Sleepiness scale) and compliance.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sleep Apnea, Obstructive
Keywords
Continuous Positive Airway Pressure, Mandibular Advancing Splint, Efficacy, Compliance, Health related quality of life, Randomized Controlled Trial, Snoring, Mandibular Advancing Appliance, Mandibular Advancing Device, Humans, Quality of Life, Sleep Apnea, Obstructive

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
119 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Continuous Positive Airway Pressure
Arm Type
Active Comparator
Arm Description
Patients treated With an auto-CPAP-machine which is a compressor Connected to a nose- or face mask which provides increased air pressure, opening the upper Airways during an apnea or hypopnea event.
Arm Title
Mandibular Advancing Splint
Arm Type
Active Comparator
Arm Description
Patients treated With a twin block splint (oral appliance) advancing the mandible and thereby opening the upper Airways for easier passage of air during sleep preventing apnea and hypopnea events.
Intervention Type
Device
Intervention Name(s)
CPAP
Other Intervention Name(s)
Resmed Autoset S9
Intervention Description
Auto-CPAP-machine for treating Obstructive Sleep Apnea With positive airway pressure
Intervention Type
Device
Intervention Name(s)
Mandibular Advancing Splint
Other Intervention Name(s)
Respire Blue, Somnodent Fusion
Intervention Description
Oral Appliance for providing an open upper airway as a mean of treating Obstructive Sleep Apnea
Primary Outcome Measure Information:
Title
Association between patient characteristics and adherence to treatment With either CPAP or MAS
Description
Combining measurements from questionnaires at baseline and 12 months to map the patient characteristics of those patients treated for mild or moderate OSA who comply, or do not comply to CPAP-intervention or MAS-intervention respectively. Detailed description of measurements collected are listed in secondary outcome measures.
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Efficacy of MAS and CPAP measured by Apnea-Hypopnea-Index (AHI). Data collected by respiratory polygraphy.
Description
Objective measurement of the efficacy of MAS or CPAP treatment in patients having mild or moderate OSA. Apnea-events/hypopnea-events and oxygen desaturation-index registered by respiratory polygraphy are combined to give an AHI-score before treatment and after 4 months of intervention.
Time Frame
4 months
Title
Efficacy of MAS and CPAP measured by Apnea-Hypopnea-Index (AHI). Data collected by respiratory polygraphy.
Description
Objective measurement of the efficacy of MAS or CPAP treatment in patients having mild or moderate OSA. Apnea-events/hypopnea-events and oxygen desaturation-index registered by respiratory polygraphy are combined to give an AHI-score before treatment and after 12 months of intervention.
Time Frame
12 months
Title
Self-reported patient compliance to MAS or CPAP collected by questionnaire
Description
Patient adherence to the use of MAS or CPAP in patients having mild or moderate OSA
Time Frame
4 months
Title
Self-reported patient compliance to MAS or CPAP collected by questionnaire
Description
Patient adherence to the use of MAS or CPAP in patients having mild or moderate OSA
Time Frame
12 months
Title
Self-reported quality of life collected by the questionnaire Short Form-36 (SF-36)
Description
Health related Quality of life at baseline and after 4 months of treatment with either MAS or CPAP in patients having mild or moderate OSA
Time Frame
4 months
Title
Self-reported quality of life collected by the questionnaire Short Form-36 (SF-36)
Description
Health related Quality of life at baseline and after 12 months of treatment with either MAS or CPAP in patients having mild or moderate OSA
Time Frame
12 months
Title
Self-reported symptoms of anxiety and/or depression collected by the questionnaire Hospital Anxiety and Depression Scale (HADS)
Description
Self reported signs on depression and anxiety at baseline and after 4 months of treatment with either MAS or CPAP in patients having mild or moderate OSA
Time Frame
4 months
Title
Self-reported symptoms of anxiety and/or depression through the questionnaire Hospital Anxiety and Depression Scale (HADS)
Description
Self reported signs on depression and anxiety at baseline and after 12 months of treatment with either MAS or CPAP in patients having mild or moderate OSA
Time Frame
12 months
Title
Self-reported experience of sleep-quality through the questionnaire Pittsburgh Sleep Quality Index (PSQI)
Description
Self perceived sleep quality at baseline and after 4 months of treatment with either MAS or CPAP in patients having mild or moderate OSA
Time Frame
4 months
Title
Self-reported experience of sleep-quality through the questionnaire Pittsburgh Sleep Quality Index (PSQI)
Description
Self perceived sleep quality at baseline and after 12 months of treatment with either MAS or CPAP in patients having mild or moderate OSA
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 10 ≤ Apnea-Hypopnea-Index ≤ 30 at baseline Subjective symptoms of OSA Ability of at least 5mm protrusion of the mandible Accept randomization of treatment modality Accept to fill in the questionnaires Accept to attend at planned consultations Exclusion Criteria: Primarily central sleep apnea Known temporomandibular dysfunction (TMD) Mental instability Drug abuse Extensive usage of sedative medication which disqualifies for OSA-treatment Extensive gag-reflex or claustrophobia Inadequate dental support (< 10 teeth in lower jaw) Inadequate periodontal support (no tooth mobility > Miller grade I) Anatomical abnormalities in the nasal cavity or oro-pharynx that disqualifies the use of CPAP and/or MAS Anatomical abnormalities which should be surgically corrected before treatment with CPAP and/or MAS Severely compromised general health condition Pregnancy General health issues that disqualifies the use of CPAP and or MAS
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Tordis A. Trovik, PhD, DDS
Organizational Affiliation
University of Tromsø, Department of Community Medicine
Official's Role
Study Chair
Facility Information:
Facility Name
St.Olavs Hospital
City
Trondheim
State/Province
Sør-Trøndelag
ZIP/Postal Code
N-7006
Country
Norway
Facility Name
University Hospital of North Norway
City
Tromsø
State/Province
Troms
ZIP/Postal Code
N-9038
Country
Norway

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Obstructive Sleep Apnea - Patient Specific Factors, Success Rate and Compliance

We'll reach out to this number within 24 hrs